Changes in the prevalence of pre-eclampsia in Akershus County and the rest of Norway during the past 35 years

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 8, 2006, Pages 916-921

  Dahlstrøm, Berit ^a   Ellström Engh, Marie ^a   Bukholm, Geir ^a   Øian, Pål ^b  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Data registration; Pre eclampsia; Prevalence; Urbanization

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; MATHEMATICAL COMPUTING; NORWAY; POPULATION RESEARCH; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; REGISTER; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

ADULT; BIRTH RATE; FEMALE; HUMANS; LIFE STYLE; NORWAY; POPULATION DYNAMICS; PRE-ECLAMPSIA; PREGNANCY; PREVALENCE; RISK FACTORS;

EID: 33746341221     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340500442449     Document Type: Article

References (15)

1. Redman CWG. Hypertension in pregnancy. In: Chamberlain G, editor. Turnbull's Obstetrics, second edition. Edinburgh: Churchill Livingstone; 1995. p. 441-70.
2. Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP, Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol. 2002; 105:94-113.
3. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol. 1988;147:1062-70.
4. Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet. 2001;357:209-15.
5. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:549-50.
6. Clausen T, Slott M, Solvoll K, Drevon CA, Vollset SE, Henriksen T. High intake of energy, sucrose, and polyunsaturated fatty acids is associated with increased risk of preeclampsia. Am J Obstet Gynecol. 2001;185:451-8.
7. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;2:252-3.
8. Nilsson E, Ros HS, Cnattingius S, Lichtenstein P. The importance of genetic and environmental effects for preeclampsia and gestational hypertension: a family study. BJOG. 2004;111:200-6.
9. Mortensen JT, Thulstrup AM, Larsen H, Møller M, Sørensen HT. Smoking, sex of the offspring, and risk of placental abruption, placenta previa, and preeclampsia: a population-based cohort study. Acta Obstet Gynecol Scand. 2001;80:894-8.
10. Report No. 49 to the Storting (2003-2004) Diversity through inclusion and participation, section 5.5.
11. Nilsson G, Petersson H, Ahlfeldt H, Strender L-E. Evaluation of three Swedish ICD-10 primary care versions: reliability and ease of use in diagnostic coding. Methods Inf Med. 2000;39:325-31.
12. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142:159-67.
13. Oian P, Maltau JM, Abyholm T. HELLP syndrome - a serious complication of hypertension in pregnancy. Acta Obstet Gynecol Scand. 1984;63:727-9.
14. Andersgaard AB, Herbst A, Johansen M, Ivarsson A, Ingemarsson I, Langhoff-Roos J et al. Eclampsia in Scandinavia: incidence, substandard care and potentially preventable cases. Acta Obstet Gynecol Scand 2006 (in press).
15. Health, care and social relations - Less smoking, but more overweight. Survey of living conditions 2002. Statistics Norway.